Bristol-Myers Squibb
BMY
BMY
1,452 hedge funds and large institutions have $75.9B invested in Bristol-Myers Squibb in 2015 Q3 according to their latest regulatory filings, with 83 funds opening new positions, 511 increasing their positions, 581 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
6% less capital invested
Capital invested by funds: $80.8B → $75.9B (-$4.89B)
10% less funds holding in top 10
Funds holding in top 10: 80 → 72 (-8)
12% less repeat investments, than reductions
Existing positions increased: 511 | Existing positions reduced: 581
Holders
1,452
Holding in Top 10
72
Calls
$755M
Puts
$760M
Top Buyers
| 1 | +$586M | |
| 2 | +$535M | |
| 3 | +$531M | |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$273M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$202M |
Top Sellers
| 1 | -$779M | |
| 2 | -$482M | |
| 3 | -$266M | |
| 4 |
JP Morgan Chase
New York
|
-$265M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$222M |